FIELD: medicine.
SUBSTANCE: present invention relates to medicine, namely to phthisiology, and concerns the complex sequential use of pathogenetic agents for the treatment of children with tuberculosis infection. To do this, a vetoron is driven once daily, 0.5-0.6 ml, diluted in 100 ml of boiled water, after meals, with a course of 1-3 months, repeated after 1 month. Additionally, with the development of intestinal dysbiosis of 2-3 degrees of severity, a daily single intake of kumis is prescribed 2 hours after taking medications, in slow sips, while a single drinking dose of kumis is 100-150 ml, and the course of intake is 3 months.
EFFECT: this sequence of administration of vitamin and fermented milk products provides an increase in the effectiveness of treatment of tuberculosis infection by increasing the immune status and eliminating hepatotoxic side reactions that develop during treatment with anti-tuberculosis drugs.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS SUFFERING PULMONARY TUBERCULOSIS | 2011 |
|
RU2456006C1 |
METHOD FOR COMPLEX CORRECTION OF INTESTINAL DYSBIOSIS WITH THE HELP OF LIQUID PROBIOTIC "NARINE-FORTE" AND PREBIOTIC SYRUP "PHYTOLON" WITH CHLOROPHYLL | 2005 |
|
RU2322251C2 |
METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2006 |
|
RU2340372C2 |
METHOD FOR TREATMENT OF INTESTINE INFECTIONS IN CHILDREN | 2002 |
|
RU2227036C2 |
METHOD FOR TREATING DISBACTERIOSIS | 2000 |
|
RU2193398C2 |
METHOD FOR CORRECTION OF ENDOGENUOUS INTOXICATION AND PREVENTION OF UNDESIRABLE SIDE REACTIONS OF ANTITUBERCULOUS MEDICATIONS IN TUBERCULOSIS PATIENTS | 2007 |
|
RU2347573C1 |
METHOD FOR TREATMENT OF FOCAL AND INFILTRATIVE PULMONARY TUBERCULOSIS | 2005 |
|
RU2297846C2 |
Pleurotus 1137 PREPARATION FOR DRUG HYPERSENSITIVITY CORRECTION IN INTEGRATED THERAPY OF PULMONARY TUBERCULOSIS | 2010 |
|
RU2435600C1 |
WAY OF PREVENTION OF COLLATERAL NEURO - CARDIO - AND HEPATOTOXIC REACTIONS TO ANTITUBERCULOUS PREPARATIONS | 2007 |
|
RU2362558C1 |
METHOD TO TREAT POLYPOSIS OF LARGE INTESTINE | 2000 |
|
RU2178300C1 |
Authors
Dates
2021-04-19—Published
2020-07-17—Filed